JMI team secures patent for research on fungal medicine

Story by  ATV | Posted by  Aasha Khosa | Date 27-09-2024
Professor Rajan Patel, Dr. Farooq Ahmed Wani  and Dr. Mohammed Abid (Left to right)
Professor Rajan Patel, Dr. Farooq Ahmed Wani and Dr. Mohammed Abid (Left to right)

 

New Delhi

The Patent Office of the Government of India has granted a patent to an important research work done under the leadership of Professor Rajan Patel and Dr. Farooq Ahmed Wani of the Department of Biosciences, Jamia Millia Islamia. Researchers Dr. Mohammad Abid, Dr. Babita Aneja, and Dr. Ahmaduddin have collaborated in this research. 

The team has developed a new process to synthesize Benzimidazolium Gemini surfactant, which acts as an effective antifungal agent. This new process is considered a significant advance in the field of pharmaceutical chemistry.

Benzimidazolium Gemini contains compounds that have proven effectiveness against a variety of fungal pathogens. Its unique molecular structure establishes better interaction with the cell membrane, thereby providing significant assistance in fighting fungal infections.

Expressing happiness on receiving the patent, Professor Patel said, "This patent is a major step forward in the research on antifungal agents. The need to treat resistant fungal infections has become extremely urgent in today's times. Our surfactant can provide a new solution to this challenge."

The process outlined in the patent details the improvement in the yield and purity of the surfactant. Preliminary studies show that this surfactant exhibits effective antifungal activity against commonly found fungal pathogens, making it potential for use in the health and agriculture sectors. This surfactant has also been made biodegradable, making it safe from an environmental point of view.

The collaboration between various experts in this research has demonstrated how important interdisciplinary research is in advancing new technologies and scientific understanding. This patent is a significant achievement for the team and puts their research at the forefront of antifungal innovation.

Professor Patel and his team are now looking for partnerships to investigate the clinical applications of their findings and for commercialization, so that this innovation can be leveraged on a wider scale.